Combining Yttrium 90–Labeled Ibritumomab Tiuxetan with High-Dose Chemotherapy and Stem Cell Support in Patients with Relapsed Non-Hodgkin's Lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Combining Yttrium 90–Labeled Ibritumomab Tiuxetan with High-Dose Chemotherapy and Stem Cell Support in Patients with Relapsed Non-Hodgkin's Lymphoma

Published:2004-10 Issue: Volume:5 Page:S22-S26
ISSN:1526-9655
Container-title:Clinical Lymphoma
language:en
Short-container-title:Clinical Lymphoma

Author:

Winter Jane N.

Publisher

Elsevier BV

Subject

Cancer Research

Reference27 articles.

1. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma;Philip;N Engl J Med,1995

2. Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma;van Besien;Blood,2003

3. Intensive therapies in follicular non-Hodgkin lymphomas;Hunault-Berger;Blood,2002

4. High-dose therapy improves progression- free survival and survival in relapsed follicular non-Hodgkin's lymphoma: results from the randomized European CUP trial;Schouten;J Clin Oncol,2003

5. Zevalin-dose escalation followed by high-dose BEAM and autotransplant in CD20+ relapsed or refractory non- Hodgkin lymphoma (NHL);Winter;Biol Blood Marrow Transplant,2004

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radioimmunotherapy;Clinical Nuclear Medicine;2020

2. Radiation Dosimetry Study of [89Zr]rituximab Tracer for Clinical Translation of B cell NHL Imaging using Positron Emission Tomography;Molecular Imaging and Biology;2014-12-11

3. Biodistribution, radiation dosimetry and scouting of 90Y-ibritumomab tiuxetan therapy in patients with relapsed B-cell non-Hodgkin’s lymphoma using 89Zr-ibritumomab tiuxetan and PET;European Journal of Nuclear Medicine and Molecular Imaging;2012-01-05

4. Cancer radioimmunotherapy;Immunotherapy;2011-03

5. Clinical outcomes of post-remission therapy using 90yttrium ibritumomab tiuxetan (Zevalin®) for high-risk patients with diffuse large B-cell lymphoma;Annals of Hematology;2011-02-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3